Neurochemical Conference 2009. Genetic and molecular biochemistry of neurological diseases in experiment and clinic. Neuroprotective strategy.

Journal Title: Pharmacological Reports - Year 2009, Vol 61, Issue 6

Abstract

Authors and Affiliations

Keywords

Related Articles

Aldosterone augments LOX-1-mediated low-density lipoprotein uptake in human umbilical artery endothelial cells.

Aldosterone and oxidized low-density lipoprotein (oxLDL) are recognized risk factors for cardiovascular disease and atherosclerosis. LOX-1 is a multi-ligand receptor originally identified as the endothelial oxLDL recepto...

The past, the present and the future of experimental research on myocardial ischemia and protection.

At present, cardiovascular diseases represent the most important health risks because they are responsible for more than 50% of total mortality. Among them, ischemic heart disease is the leading cause of morbidity and mo...

Yohimbine-induced alterations in alpha(2)-adrenoceptors in kidney regions of the spontaneously hypertensive rats: an autoradiographic analysis.

We have tested the hypothesis that a pharmacologically determined alteration in renal alpha(2)-adrenoceptor (alpha(2)-AR) density might be a pathophysiologically important factor of genetic hypertension in the spontaneou...

Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: Implications for reactive oxygen species.

Type 2 diabetes mellitus is associated with clustering of cardiovascular risk factors that may greatly increase individuals' risk of developing coronary artery disease. Type 2 diabetes is believed to impair coronary func...

Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse.

Nicotinamide N-methyltransferase (NNMT), which converts nicotinamide (NA) to 1-methylnicotinamide (MNA), is up-regulated in the cirrhotic liver. Because MNA displays PGI(2)-dependent anti-inflammatory effects, the up-reg...

Download PDF file
  • EP ID EP129137
  • DOI -
  • Views 82
  • Downloads 0

How To Cite

(2009). Neurochemical Conference 2009. Genetic and molecular biochemistry of neurological diseases in experiment and clinic. Neuroprotective strategy.. Pharmacological Reports, 61(6), 1223-1253. https://europub.co.uk/articles/-A-129137